Europe Viscosupplementation Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	163 Pages	Coherent Market Insights	July, 2023	CMI18107717

Best Price Guarantee
Price	from $4,500
Length	163 Pages
Publisher	Coherent Market Insights
Published Date	July, 2023
SKU	CMI18107717

Europe Viscosupplementation Market, By Type (Single Injection, Cycle Three Injection Cycle, Five Injection Cycle), By End User (Hospitals, ASCs, Clinics), By Country (Western Europe (Germany, UK, France, Italy, Spain, Nordic Countries, Rest of Western Europe), Eastern Europe (Russia, Rest of Eastern Europe))- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Viscosupplementation is a therapeutic process in which the pathological synovial fluid or effusion is removed from the joint by arthrocentesis and is replaced with a highly purified hyaluronan solution which has a 16- to 30-times greater concentration than the pathological joint fluid, and a 2- to 5-times than that of the hyaluronan in the healthy synovial fluid. In some preparations of hyaluronan for therapeutic purposes, the rheological properties (viscosity and elasticity) are low, and therefore the elastoviscosity of the fluid is similar to that of fluid removed from an arthritic joint. Another preparation available to patients worldwide is composed of hyaluronan derivatives (hylans) with substantially greater elastoviscosity than hyaluronan solutions and has comparable rheological properties to those of the fluid found in young, healthy individuals.

Market Dynamics

The key market players are focusing on the adoption of growth strategies such as partnerships and product launches, which is attributed to the growth of the Europe viscosupplementation market. For instance, in May 2022, Fidia Farmaceutici S.p.A., produces medical products and offers hyaluronic acid products for intra-articular injection, hyaluronic acid treatments used in tissue repair to treat general wounds, ulcers, bedsores, and topical treatment of burns and skin lesions in Italy, launched its Aesthetic Care portfolio with a scientific symposium on its innovative ACP (Auto-Crosslinked Polymer) technology at the 20th Aesthetic & Anti-aging Medicine World Congress 2022 (AMWC) in Monte Carlo held in 2022. The company launched its complete Hyal System and Hy-Tissue portfolio in Spain. This helped the company to showcase its research for hyaluronic acid in Spain.

Key features of the study:

This report provides an in-depth analysis of Europe viscosupplementation market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the Europe viscosupplementation market based on the following parameters– Company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include include Sanofi S.A., Anika Therapeutics, Inc., Seikagaku, Zimmer Biomet Holdings Inc., Meda AB (Mylan), Fidia Farmaceutici S.p.A., Bioventus LLC, Ferring B.V, Lifecore Biomedical, OrthogenRx, Inc. (a subsidiary of AVNS), APTISSEN, Johnson & Johnson Services, Inc., Viatris Inc., IBSA Institut Biochimique SA, Ortobrand International, TRB CHEMEDICA SA, Teva Pharmaceutical Industries Ltd., Lifecore (a subsidiary of Landec Corporation), VIRCHOW BIOTECH, Zuventus HealthCare Ltd. (a subsidiary of Emcure Pharmaceuticals), and LG Life Sciences.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Europe viscosupplementation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Europe viscosupplementation market

Detailed Segmentation:

Europe Viscosupplementation Market, By Type:
Single Injection Cycle
Three Injection Cycle
Five Injection Cycle
Europe Viscosupplementation Market, By End User:
Hospitals
ASCs
Clinics
Europe Viscosupplementation Market, By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Company Profiles
Sanofi S.A.
Anika Therapeutics, Inc.
Seikagaku
Zimmer Biomet Holdings Inc.
Meda AB (Mylan)
Fidia Farmaceutici S.p.A.
Bioventus LLC
Ferring B.V
Lifecore Biomedical
OrthogenRx, Inc. (a subsidiary of AVNS)
APTISSEN
Johnson & Johnson Services, Inc.
Viatris Inc.
IBSA Institut Biochimique SA
Ortobrand International
TRB CHEMEDICA SA
Teva Pharmaceutical Industries Ltd.
Lifecore (a subsidiary of Landec Corporation)
VIRCHOW BIOTECH
Zuventus HealthCare Ltd. (a subsidiary of Emcure Pharmaceuticals)
LG Life Sciences

1. Research Objective and Assumption: Research Objectives; Assumptions; Abbreviations
2. Market Purview: Report Description; Market Definition and Scope; Executive Summary; Market Snippet, By Product Type; Market Snippet, By End User; Market Snippet, By Country; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis: Market Dynamics; Drivers; Restraints; Market Opportunities; Impact Analysis; Recent Product Launches; Epidemiology; Merger, Acquisition, and Collaborations; Regulatory Scenario; Key Developments; PEST Analysis
4. Europe Viscosupplementation Market- Impact of Coronavirus (Covid-19) Pandemic: Economic Impact; COVID-19 Epidemiology; Impact on Supply and Demand
5. Europe Viscosupplementation Market, By Type, 2018–2030 (US$ Mn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018–2030; Segment Trends; Single Injection Cycle; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn); Segment Trends; Three Injection Cycle; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn); Segment Trends; Five Injection Cycle; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn); Segment Trends
6. Europe Viscosupplementation Market, By End User, 2018–2030 (US$ Mn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018–2030; Segment Trends; Hospitals; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn); ASCs); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn); Clinics; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn)
7. Europe Viscosupplementation Market, By Country, 2018–2030 (US$ Mn): Europe; Introduction; Market Size and Forecast, By Type, 2018–2030, (US$ Mn); Market Size and Forecast, By End User, 2018–2030, (US$ Mn); Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn); U.K.; Introduction; Market Size and Forecast, By Type, 2018–2030, (US$ Mn); Market Size and Forecast, By End User, 2018–2030, (US$ Mn); Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn); Germany; Introduction; Market Size and Forecast, By Type, 2018–2030, (US$ Mn); Market Size and Forecast, By End User, 2018–2030, (US$ Mn); Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn); Italy; Introduction; Market Size and Forecast, By Type, 2018–2030, (US$ Mn); Market Size and Forecast, By End User, 2018–2030, (US$ Mn); Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn); France; Introduction; Market Size and Forecast, By Type, 2018–2030, (US$ Mn); Market Size and Forecast, By End User, 2018–2030, (US$ Mn); Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn); Spain; Introduction; Market Size and Forecast, By Type, 2018–2030, (US$ Mn); Market Size and Forecast, By End User, 2018–2030, (US$ Mn); Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn); Russia; Introduction; Market Size and Forecast, By Type, 2018–2030, (US$ Mn); Market Size and Forecast, By End User, 2018–2030, (US$ Mn); Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn); Rest of Europe; Introduction; Market Size and Forecast, By Type, 2018–2030, (US$ Mn); Market Size and Forecast, By End User, 2018–2030, (US$ Mn); Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn)
8. Competitive Landscape: Company Profiles; Sanofi S.A.; Company Overview; Product Portfolio; Key Developments; Financial Performance; Strategies; Anika Therapeutics, Inc.; Company Overview; Product Portfolio; Key Developments; Financial Performance; Strategies; Seikagaku; Company Overview; Product Portfolio; Key Developments; Financial Performance; Strategies; Zimmer Biomet Holdings Inc.; Company Overview; Product Portfolio; Key Developments; Financial Performance; Strategies; Meda AB (Mylan); Company Overview; Product Portfolio; Key Developments; Financial Performance; Strategies; Fidia Farmaceutici S.p.A.; Company Overview; Product Portfolio; Key Developments; Financial Performance; Strategies; Bioventus LLC; Company Overview; Product Portfolio; Key Developments; Financial Performance; Strategies; Ferring B.V; Company Overview; Product Portfolio; Key Developments; Financial Performance; Strategies; Lifecore Biomedical; Company Overview; Product Portfolio; Key Developments; Financial Performance; Strategies; OrthogenRx, Inc. (a subsidiary of AVNS); Company Overview; Product Portfolio; Key Developments; Financial Performance; Strategies; APTISSEN; Company Overview; Product Portfolio; Key Developments; Financial Performance; Strategies; Johnson & Johnson Services, Inc.; Company Overview; Product Portfolio; Key Developments; Financial Performance; Strategies; Viatris Inc.; Company Overview; Product Portfolio; Key Developments; Financial Performance; Strategies; IBSA Institut Biochimique SA; Company Overview; Product Portfolio; Key Developments; Financial Performance; Strategies; Ortobrand International; Company Overview; Product Portfolio; Key Developments; Financial Performance; Strategies; TRB CHEMEDICA SA; Company Overview; Product Portfolio; Key Developments; Financial Performance; Strategies; Teva Pharmaceutical Industries Ltd.; Company Overview; Product Portfolio; Key Developments; Financial Performance; Strategies; Lifecore (a subsidiary of Landec Corporation); Company Overview; Product Portfolio; Key Developments; Financial Performance; Strategies; VIRCHOW BIOTECH; Company Overview; Product Portfolio; Key Developments; Financial Performance; Strategies; Zuventus HealthCare Ltd. (a subsidiary of Emcure Pharmaceuticals); Company Overview; Product Portfolio; Key Developments; Financial Performance; Strategies; LG Life Sciences.; Company Overview; Product Portfolio; Key Developments; Financial Performance; Strategies
9. Section: References; Research Methodology; About us and Sales Contact; *Browse 34 market data tables and 26 figures on “Europe Viscosupplementation Market”– forecast to 2030